Prevention & Chronic Conditions

Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Risk Prediction of CVD in the Asia-Pacific Region

Published:

29 November 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e43.

GLP-1RA in Different HFpEF Phenotypes

Published:

16 October 2024

Citation:

Cardiac Failure Review 2024;10:e14.

COVID-19 and Cardiovascular Care in Asia-Pacific

Published:

29 July 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e32.

Heart Failure in South Asians

Published:

16 July 2024

Citation:

Cardiac Failure Review 2024;10:e07.